Company / Net Income
Neurogene Inc. Net Income History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$75.1M
FY2025
5-year range
-$75.1M / -$36.3M
FY2021-FY2025
Trend
-106.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$50M to -$75M over the past 6 years.
Based on SEC 10-K filings.
-$75M in FY2025.
Declined from -$50M to -$75M over the past 6 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income decreased 106.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.24 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$75.1M | -106.9% |
| FY2024 | -$36.3M | +27.6% |
| FY2019 | -$50.2M | -35.6% |
| FY2018 | -$37.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026